ERBB3 and ovarian carcinoma: The downstream genes of NOX4, such as HER3 or/and NF-κB, may play important roles in the regulation of therapeutic sensitivity, which may provide an experimental basis for further investigation into improving ovarian cancer treatment and prognosis in the future.